A composite nanocarrier to inhibit precipitation of the weakly basic drug in the gastrointestinal tract

References

• Aguiar J, Carpena P, Molina-Bolı́Var JA, and, Ruiz CC. (2003). On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J Colloid Interface Sci 258:116–22.
   Web of Science ®Google Scholar
• Anby MU, Williams HD, Mcintosh M, et al. (2012). Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. Mol Pharm 9:2063–79.
   PubMed Web of Science ®Google Scholar
• Andreas C, Joanne VR, Regina S, et al. (2012). Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol 68:607–16.
   PubMed Web of Science ®Google Scholar
• Andrew C, Cameron W. (2012). The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers. Xenobiotica 42:538–49.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Rosencher N, Eriksson BI. (2009). Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate. Patient Prefer Adherence 3:173–7.
   PubMed Web of Science ®Google Scholar
• Cagel M, Bernabeu E, Gonzalez L, et al. (2017). Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil®. Biomed Pharmacother 95:894–903.
   PubMed Web of Science ®Google Scholar
• Chai F, Sun L, Ding Y, et al. (2016). A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. Nanomedicine 11:1801–16.
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. (2007). Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 4:465–74.
   PubMed Web of Science ®Google Scholar
• Craig DQM. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 231:131–44.
   PubMed Web of Science ®Google Scholar
• Dabholkar RD, Sawant RM, Mongayt DA, et al. (2006). Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315:148–57.
   PubMed Web of Science ®Google Scholar
• Dai WG. (2010). In vitro methods to assess drug precipitation. Int J Pharm 393:1–16.
   PubMed Web of Science ®Google Scholar
• Diao YY, Han M, Chen DW, Gao JQ. (2009). Progress in the study of micelle delivery system reversing multidrug resistance. Acta Pharma Sin 44:710–15.
   PubMedGoogle Scholar
• Dou J, Zhang H, Liu X, et al. (2014). Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration. Colloids Surf B Biointerfaces 114:20–7.
   PubMed Web of Science ®Google Scholar
• Duan Y, Zhang B, Chu L, et al. (2016). Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration. Colloids Surf B Biointerfaces 141:345–54.
   PubMed Web of Science ®Google Scholar
• Fan Y, Yuan S, Huo M, et al. (2017a). Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue. Nanomed Nanotechnol Biol Med 13:1399–410.
   PubMed Web of Science ®Google Scholar
• Fan Z, Jin B, Xiafang XU, et al. (2017b). Preparation and in vitro antitumor evaluation of curcumin-loaded micelles. J Wenzhou Med Univ 47:625–36.
   Google Scholar
• Ganetsky M, Babu K, Salhanick S, et al. (2011). Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol 7:281–7.
   PubMedGoogle Scholar
• Ge L, He X, Zhang Y, et al. (2017). A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract. Nanomed Nanotechnol Biol Med 12:3605–16.
   Google Scholar
• Greig SL, Mckeage K. (2014). Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence. Drugs 74:1785–800.
   PubMed Web of Science ®Google Scholar
• Gu CH, Rao D, Gandhi RB, et al. (2005). Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci 94:199–208.
   PubMed Web of Science ®Google Scholar
• Guo Q, Cai J, Li P, et al. (2016). Comparison of bile salt/phosphatidylcholine mixed micelles in solubilization to sterols and stability. DDDT 10:3789–98.
   PubMed Web of Science ®Google Scholar
• Härtter S, Koenen-Bergmann M, Sharma A, et al. (2012a). Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin. Br J Clin Pharmacol 74:490–500.
   PubMed Web of Science ®Google Scholar
• Härtter S, Sennewald R, Nehmiz G, Reilly P. (2012b). Oral bioavailability of dabigatran etexilate (Pradaxa((R))) after co-medication with verapamil in healthy subjects. Br J Clin Pharmacol 75:1053–62.
   Web of Science ®Google Scholar
• Hunter J, Jepson MA, Tsuruo T, et al. (1993). Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem 268:14991–7.
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Kishimoto W, Volz A, et al. (2014). Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayers. Drug Metab Dispos 42:250–6.
   PubMed Web of Science ®Google Scholar
• Rubbens J, Brouwers J, Tack J, Augustijns P. (2016). Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers. Eur J Pharm Biopharm 109:122–9.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wu Z, Li C, et al. (2018). Optimization of weight ratio for DSPE-PEG/TPGS hybrid micelles to improve drug retention and tumor penetration. Pharm Res 35:13.
   PubMed Web of Science ®Google Scholar
• Kalyanasundaram K, Thomas JK. (1977). Solvent-dependent fluorescence of pyrene-3-carboxaldehyde and its applications in the estimation of polarity at micelle-water interfaces. J Phys Chem 81:2176–80.
   Web of Science ®Google Scholar
• Kim JH, Domach MM, Tilton RD. (1999). Pyrene solubilization capacity in octaethylene glycol monododecyl ether (C 12 E 8) micelles. Colloids Surf A Physicochem Eng Asp 150:55–68.
   Web of Science ®Google Scholar
• Kostewicz ES, Wunderlich M, Brauns U, et al. (2004). Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol 56:43–51.
   PubMed Web of Science ®Google Scholar
• Lai SK, O'Hanlon DE, Harrold S, et al. (2007). Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci USA 104:1482–7.
   PubMed Web of Science ®Google Scholar
• Letchford K, Burt H. (2007). A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. Eur J Pharm Biopharm 65:259–69.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50:47–60.
   PubMed Web of Science ®Google Scholar
• Li S, Pollock-Dove C, Dong LC, et al. (2012). Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study. Mol Pharm 9:1100–8.
   PubMed Web of Science ®Google Scholar
• Liu G, Zhang D, Jiao Y, et al. (2012). Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology. Int J Pharm 422:516–22.
   PubMed Web of Science ®Google Scholar
• Makhey VD, Guo A, Norris DA, et al. (1998). Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15:1160–7.
   PubMed Web of Science ®Google Scholar
• Mathot F, des Rieux A, Ariën A, et al. (2007). Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier. J Control Release 124:134–43.
   PubMed Web of Science ®Google Scholar
• Mu L, Seow PH. (2006). Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B Biointerfaces 47:90–7.
   PubMed Web of Science ®Google Scholar
• Mundada V, Sawant K. (2018). Enhanced oral bioavailability and anticoagulant activity of dabigatran etexilate by self-micro emulsifying drug delivery system: systematic development, in vitro, ex vivo and in vivo evaluation. J Nanomed Nanotechnol 09: 480–92.
   Google Scholar
• Paikin JS, Haroun MJ, Eikelboom JW. (2011). Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial. Expert Rev Cardiovasc Ther 9:279–86.
   PubMedGoogle Scholar
• Parikh T, Sandhu HK, Talele TT, Serajuddin ATM. (2016). Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharm Res 33:1456–71.
   PubMed Web of Science ®Google Scholar
• Poelma FG, Breäs R, Tukker JJ, Crommelin DJ. (1991). Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat. J Pharm Pharmacol 43:317–24.
   PubMed Web of Science ®Google Scholar
• Pollak AW, McBane RD. (2014). Succinct review of the new VTE prevention and management guidelines. Mayo Clin Proc 89:394–408.
   PubMed Web of Science ®Google Scholar
• Punčochová K, Prajzlerová M, Beránek J, Štěpánek F. (2016). The impact of polymeric excipients on the particle size of poorly soluble drugs after pH-induced precipitation. Eur J Pharm Sci 95:138–44.
   PubMed Web of Science ®Google Scholar
• Quan G, Boyi N, Vikramjeet S, et al. (2017). Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement. IJN 12:8801–11.
   Web of Science ®Google Scholar
• Rajesh K, Parikh D, Delvadia R, Patel S. (2006). A novel multicompartment dissolution apparatus for evaluation of floating dosage form containing poorly soluble weakly basic drug. Dissolution Technol 13:14–19.
   Google Scholar
• Ran M, Xiang J, Nan L, et al. (2011). The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–20.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. (2007). Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603–16.
   PubMed Web of Science ®Google Scholar
• Stangier DJ. (2008). Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 47:285–95.
   PubMed Web of Science ®Google Scholar
• Suys EJA, Chalmers DK, Pouton CW, Porter CJH. (2018). Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a Type IV lipid-based formulation. Mol Pharm 15:2355–71.
   PubMed Web of Science ®Google Scholar
• Tatavarti AS, Hoag SW. (2006). Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices. J Pharm Sci 95:1459–68.
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mols R, Mellaerts R, et al. (2010). Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm 75:354–65.
   PubMed Web of Science ®Google Scholar
• Wang RB, Kuo CL, Lien LL, Lien EJ. (2003). Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors. J Clin Pharm Ther 28:203–28.
   PubMed Web of Science ®Google Scholar
• Wang XR, Liu P, Wang SH, et al. (2013). Influence of pH on dissolution and oil-water partition coefficient of dabigatran etexilate. Chin J New Drugs 22:2933–7.
   Google Scholar
• Wienen W, Stassen JM, Priepke H, et al. (2007). Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats. Thromb Haemost 98:333–8.
   PubMed Web of Science ®Google Scholar
• Wignot TM, Stewart RP, Schray KJ, et al. (2004). In vitro studies of the effects of HAART drugs and excipients on activity of digestive enzymes. Pharm Res 21:420–7.
   PubMed Web of Science ®Google Scholar
• Wilcox R, Pendleton RC, Smock KJ, Rodgers GM. (2011). Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice. Hosp Pract 39:23–34.
   Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. (2013). Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499.
   PubMed Web of Science ®Google Scholar
• Xie Z, Lu T, Chen X, et al. (2007). Triblock poly(lactic acid)-b-poly(ethylene glycol)-b-poly(lactic acid)/paclitaxel conjugates: synthesis, micellization, and cytotoxicity. J Appl Polym Sci 105:2271–9.
   Web of Science ®Google Scholar
• Yan H, Jie S, Zhang Z, Jia X. (2016). Optimization and anticancer activity in vitro and in vivo of baohuoside I incorporated into mixed micelles based on lecithin and solutol HS 15. Drug Deliv 23:2911–18.
   PubMed Web of Science ®Google Scholar
• Yuan T, Xiaoqian J, Liangzhi L, et al.; S.O. Pharmacy and J.M. University. (2018). Improvement of the dissolution behavior of dabigatran etexilate by three-dimensional ordered macroporous starch material. Chin J Mod Appl Pharm 35:213–16.
   Google Scholar
• Zanetti-Ramos BG, Lemos-Senna E, Soldi V, et al. (2006). Polyurethane nanoparticles from a natural polyol via miniemulsion technique. Polymer 47:8080–7.
   Web of Science ®Google Scholar
• Zhai Y, Guo S, Liu C, et al. (2013). Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloids Surf A Physicochem Eng Asp 429:24–30.
   Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel. Comput Methods Programs Biomed 99:306–14.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xv Y, Wang C, et al. (2017). Soluplus®/TPGS mixed micelles for dioscin delivery in cancer therapy. Drug Dev Ind Pharm 43:1–21.
   PubMed Web of Science ®Google Scholar
• Zhong T, He B, Cao H-q, et al. (2017). Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles. Acta Pharmacol Sin 38:924–30.
   PubMed Web of Science ®Google Scholar
• Zhou W, Li C, Wang Z, et al. (2016a). Factors affecting the stability of drug-loaded polymeric micelles and strategies for improvement. J Nanopart Res 18:275.
   Web of Science ®Google Scholar
• Zhou W, Li C, Wang Z, et al. (2016b). Factors affecting the stability of drug-loaded polymeric micelles and strategies for improvement. J Nanopart Res 18:1–18.
   Web of Science ®Google Scholar